Actualités Enzymotec Ltd. - Ordinary Shares (delisted) - ENZY | Actions NASDAQ

Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px;...

Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme

Press release 30 January 2019 First patients included in large placebo-controlled multicentre study on ColdZyme Enzymatica has initiated a...

Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claims

Press release 25 January 2019 Results from German multicentre study strengthen and broaden ColdZyme's product claims At the Icelandic...

Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled

Press release December 10, 2018 Appeal on Enzymatica's cold spray in Germany overruled Enzymatica has been informed that the Frankfurt Higher...

Enzymatica AB: Enzymatica raises SEK 98.7 million in completed share issue

Press release December 2, 2018 NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONGKONG, JAPAN, CANADA...

Enzymatica AB: Prospectus for Enzymatica's rights issue with preferential rights for existing shareholders published

Press release November 12, 2018 NOT FOR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, HONGKONG, JAPAN, CANADA...

Enzymatica AB: Bulletin from Extraordinary General Meeting in Enzymatica AB (publ)

Press release5 November, 2018 Bulletin from Extraordinary General Meeting in Enzymatica AB (publ) Today's Extraordinary General Meeting in...

Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent

Press release November 2, 2018 Enzymatica's rights issue is secured up to 100 percent Enzymatica announced on October 18, 2018 that the...

Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany

Interim report for Enzymatica AB (publ)JANUARY-SEPTEMBER...

Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ)

The English text is an unofficial translation. In case of any discrepancies between the Swedish text and the English translation, the Swedish text...

Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million

Press release October 18, 2018 The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million The Board of Directors of...

Enzymatica AB: Enzymatica signs agreement for the Japanese market

Press release October 18, 2018 Enzymatica signs agreement for the Japanese market Enzymatica has entered into an agreement with a large Japanese...

Enzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold sympto...

Press Release October 1, 2018 Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold symptom...

Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany

Press release August 29, 2018 Appeal of court ruling on Enzymatica's cold spray in Germany Enzymatica's distributor in Germany has...

Enzymatica AB: Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa

Press releaseLund July 31, 2018 Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa Enzymatica has entered...

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY)

Outils de qualité professionnelle, pour des investisseurs individuels.

Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY) Actualités

Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany

Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme

Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claims

Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled

Enzymatica AB: Enzymatica raises SEK 98.7 million in completed share issue

Enzymatica AB: Prospectus for Enzymatica's rights issue with preferential rights for existing shareholders published

Enzymatica AB: Bulletin from Extraordinary General Meeting in Enzymatica AB (publ)

Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent

Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany

Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ)

Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million

Enzymatica AB: Enzymatica signs agreement for the Japanese market

Enzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold sympto...

Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany

Enzymatica AB: Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY)

Outils de qualité professionnelle, pour des investisseurs individuels.

Enzymotec Ltd. - Ordinary Shares (delisted) (ENZY) Actualités

Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany

Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme

Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claims

Enzymatica AB: Appeal on Enzymatica's cold spray in Germany overruled

Enzymatica AB: Enzymatica raises SEK 98.7 million in completed share issue

Enzymatica AB: Prospectus for Enzymatica's rights issue with preferential rights for existing shareholders published

Enzymatica AB: Bulletin from Extraordinary General Meeting in Enzymatica AB (publ)

Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent

Enzymatica AB: Breakthrough agreement for Japan and lower sales in Q3 due to restrictions in Germany

Enzymatica AB: Notice of Extraordinary General Meeting in Enzymatica AB (publ)

Enzymatica AB: The Board of Directors of Enzymatica AB decides on rights issue of SEK 98.7 million

Enzymatica AB: Enzymatica signs agreement for the Japanese market

Enzymatica AB: Significant benefits from ColdZyme in a major German multicenter study evaluating different common cold sympto...

Enzymatica AB: Appeal of court ruling on Enzymatica's cold spray in Germany

Enzymatica AB: Enzymatica signs agreement for ColdZyme with ABEX Pharmaceutica (Pty) Ltd for South Africa

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités